<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9108139</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">35578209</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">9108139</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">2705</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1186/s12883-022-02705-2</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Baseline characteristics between MMD patients and HCs</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics between MMD patients and HCs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">MMD (<italic>n</italic> = 22)</th><th align="left">HC (<italic>n</italic> = 10)</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left"><bold>Age (y) (mean ± SD)</bold></td><td align="left">46.8 ± 8.9</td><td align="left">49.7 ± 5.4</td><td align="left">0.638</td></tr><tr><td align="left"><bold>Gender (men/women)</bold></td><td align="left">3/19</td><td align="left">2/8</td><td align="left">0.506</td></tr><tr><td align="left"><bold>Education (y)</bold></td><td align="left">8.7 ± 2.9</td><td align="left">9.0 ± 3.7</td><td align="left">0.352</td></tr><tr><td align="left"><bold>MMSE (mean ± SD)</bold></td><td align="left">24.9 ± 4.1</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left"><bold>MoCA</bold></td><td align="left">20.2 ± 6.5</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left"><bold>Working memory</bold></td><td align="left">3.4 ± 1.4</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left"><bold>TMT-A (s)</bold></td><td align="left">97.5 ± 46.0</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left"><bold>TMT-B (s)</bold></td><td align="left">191.7 ± 89.6</td><td align="left">/</td><td align="left">/</td></tr></tbody></table><table-wrap-foot><p>Due to data loss in the early collection stage of this study, there are nineteen MMD patients in MMSE, MoCA, and working memory, and fourteen MMD patients in TMT-A and TMT-B</p><p><italic>MMD</italic> Moyamoya Disease, <italic>HC</italic> Healthy Controls, <italic>MMSE</italic> Mini–Mental State Examination, <italic>MoCA</italic> Montreal Cognitive Assessment, <italic>TMT-A/-B</italic> Trail Making Test parts A and B</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Baseline characteristics between MMD patients and HCs</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">MMD (n = 22)</th><th align="left">HC (n = 10)</th><th align="left">P value</th></tr></thead><tbody><tr><td align="left">Age (y) (mean ± SD)</td><td align="left">46.8 ± 8.9</td><td align="left">49.7 ± 5.4</td><td align="left">0.638</td></tr><tr><td align="left">Gender (men/women)</td><td align="left">3/19</td><td align="left">2/8</td><td align="left">0.506</td></tr><tr><td align="left">Education (y)</td><td align="left">8.7 ± 2.9</td><td align="left">9.0 ± 3.7</td><td align="left">0.352</td></tr><tr><td align="left">MMSE (mean ± SD)</td><td align="left">24.9 ± 4.1</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left">MoCA</td><td align="left">20.2 ± 6.5</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left">Working memory</td><td align="left">3.4 ± 1.4</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left">TMT-A (s)</td><td align="left">97.5 ± 46.0</td><td align="left">/</td><td align="left">/</td></tr><tr><td align="left">TMT-B (s)</td><td align="left">191.7 ± 89.6</td><td align="left">/</td><td align="left">/</td></tr></tbody></table></div>Due to data loss in the early collection stage of this study, there are nineteen MMD patients in MMSE, MoCA, and working memory, and fourteen MMD patients in TMT-A and TMT-BMMD Moyamoya Disease, HC Healthy Controls, MMSE Mini–Mental State Examination, MoCA Montreal Cognitive Assessment, TMT-A/-B Trail Making Test parts A and B</transformed-table></extracted-table></extracted-tables-set>